Increasing Liver Cancer Treatment Options
The FDA expanded the use of a molecularly targeted therapeutic to treat patients with the most common type of liver cancer, hepatocellular carcinoma.
The FDA expanded the use of a molecularly targeted therapeutic to treat patients with the most common type of liver cancer, hepatocellular carcinoma.
Following dietary recommendations may reduce the risk of several cancers, a study in the AACR journal Cancer Research reports. Learn more.
A recent study found that less than 13 percent of baby boomers were screened for the virus despite the recent approval of several effective treatments. Almost half of liver cancer cases in the United...
Mexican-Americans face different – and perhaps greater – risks for developing liver cancer than Mexican residents. Liver cancer is a relatively rare cancer type, but its incidence and mortality have been on the rise...
The FDA expanded an immunotherapeutic to used for treating patients with hepatocellular carcinoma – the most common form of primary liver cancer.
The FDA expanded the use of regorafenib to treat certain patients with the most common form of liver cancer diagnosed in the U.S. – hepatocellular carcinoma.
Each of the three obesity-related factors, body mass index (BMI), waist size, and type 2 diabetes, was associated with liver cancer risk in a large study.
Researchers urge better regulation to protect public health It’s no surprise that air pollution has been linked with lung cancer. A new study suggests that pollution is also associated with increased risk of mortality...